Airain Ltd’s Impax Laboratories, Inc. IPXL Stock Holding History

Airain Ltd’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,739	Closed	-$492K	–	942
2016 Q3	$492K	Buy	+20,739	New	+$557K	0.03%	440
2015 Q4	–	Sell	-26,307	Closed	-$926K	–	1173
2015 Q3	$926K	Buy	+26,307	New	+$1.19M	0.06%	345
2013 Q3	–	Sell	-30,812	Closed	-$614K	–	733
2013 Q2	$614K	Buy	+30,812	New	+$547K	0.09%	237

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Airain Ltd's IPXL Position: Q4 2016 in Review

Airain Ltd sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 20,739 shares — an estimated $492K sold.

Airain Ltd first reported a position in IPXL in Q2 2013 and held it in 3 quarters. The position peaked at $926K in Q3 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

Airain Ltd reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
Airain Ltd sold 20,739 Impax Laboratories, Inc. shares in Q4 2016, an estimated $492K.
Airain Ltd first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 3 quarters.
Airain Ltd's Impax Laboratories, Inc. position peaked at $926K in Q3 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Airain Ltd's 13F filing for Q4 2016, filed 10 Feb 2017.